Revolution Medicines, Inc. (RVMD)
98.40
-1.24
(-1.24%)
USD |
NASDAQ |
Mar 06, 16:00
98.50
+0.10
(+0.10%)
Pre-Market: 20:00
Revolution Medicines Free Cash Flow : -913.73M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 5.964B |
| Merck & Co., Inc. | 12.36B |
| AbbVie, Inc. | 17.82B |
| Tango Therapeutics, Inc. | -139.93M |
| Insmed, Inc. | -997.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -274.24M |
| Cash from Investing (Quarterly) | 74.88M |
| Cash from Financing (Quarterly) | 365.66M |
| Free Cash Flow Per Share (Quarterly) | -1.404 |
| Free Cash Flow to Equity (Quarterly) | -544.85M |
| Free Cash Flow to Firm (Quarterly) | -264.23M |
| Free Cash Flow Yield | -4.87% |